ENLIE Pharmaceutical JSC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000BCP6
VND
11,000.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

-8.15%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.98%
0%
-5.98%
6 Months
-5.17%
0%
-5.17%
1 Year
2.8%
0%
2.8%
2 Years
15.79%
0%
15.79%
3 Years
41.03%
0%
41.03%
4 Years
-6.78%
0%
-6.78%
5 Years
0%
0%
0.0%

ENLIE Pharmaceutical JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-26.15
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.94
Sales to Capital Employed (avg)
12,069.16
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.28%
ROE (avg)
6.35%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-9.33
EV to EBITDA
-91.59
EV to Capital Employed
0.49
EV to Sales
0.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.20%
ROE (Latest)
-8.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Bearish
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by ENLIE Pharmaceutical JSC"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 57.58% vs 40.02% in Dec 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 66.51% vs 62.56% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "118,986.00",
          "val2": "75,507.20",
          "chgp": "57.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,059.10",
          "val2": "-2,241.70",
          "chgp": "325.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3,086.70",
          "val2": "1,277.00",
          "chgp": "141.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,440.90",
          "val2": "-4,302.80",
          "chgp": "66.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.10%",
          "val2": "-62.50%",
          "chgp": "7.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
118,986.00
75,507.20
57.58%
Operating Profit (PBDIT) excl Other Income
5,059.10
-2,241.70
325.68%
Interest
3,086.70
1,277.00
141.71%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1,440.90
-4,302.80
66.51%
Operating Profit Margin (Excl OI)
15.10%
-62.50%
7.76%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2022 is 57.58% vs 40.02% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 66.51% vs 62.56% in Dec 2021

stock-summaryCompany CV
About ENLIE Pharmaceutical JSC stock-summary
stock-summary
ENLIE Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Enlie Pharmaceutical Joint Stock Company, formerly Becamex Pharmaceutical Joint Stock Company, is a Vietnam-based company operating in the pharmaceutical industry. The Company is mainly engaged in the production and commerce of pharmaceutical preparations, as well as medical equipment and health supplements. Besides, it has expanded its business into the real estate industry, with the development of various commercial and residential infrastructures for lease.
Company Coordinates stock-summary
Company Details
Duong NA6, KCN My Phuoc 2, Ben Cat , BINH DUONG None : None
stock-summary
Tel: 84 27 43553326
stock-summary
stock-summary
Registrar Details